Evidence map›Paper›PMID 27473536›Full record

ArticleBMC complementary and alternative medicine2016

Hepatoprotective activity of ethanolic extract of Salix subserrata against CCl4-induced chronic hepatotoxicity in rats.

Ahmed Wahid, Ashraf N Hamed, Heba M Eltahir, Mekky M Abouzied

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 55 citations in OpenAlex.

  1. Phenolic Compounds Isolated fromMolecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Hepatoprotective Potential ofCurrent drug discovery technologies · 2025
    Review
  5. Article
  6. Article
  7. Ethanolic Extract ofJournal of toxicology · 2024
    Article
  8. Article
  9. Article
  10. Evaluation of Hepatoprotective Potential of Polyherbal Preparations in CClAdvances in pharmacological and pharmaceutical sciences · 2022
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Phenolic Compounds fromMolecules (Basel, Switzerland) · 2019
    Article
  19. Article
  20. Protective effects ofWorld journal of gastroenterology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Ahmed WahidBiochemistry Department, Faculty of Pharmacy, Minia University, 61519, Minia, Egypt.
Ashraf N HamedPharmacognosy Department, Faculty of Pharmacy, Minia University, 61519, Minia, Egypt.
Heba M EltahirDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Medina, Kingdom of Saudi Arabia.
Mekky M AbouziedDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Medina, Kingdom of Saudi Arabia. m_meky2001@yahoo.com.
Minia University · EGTaibah University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe liver performs diverse functions that are essential for life. In the absence of reliable liver protective drugs, a large number of natural medicinal preparations are used for the treatment of liver diseases. Therefore the present study aims to investigate the hepatoprotective effects of Salix subserrata Willd flower ethanolic extract (SFEE) against carbon tetrachloride (CCl4)-induced liver damage.

methodsRats were divided into 4 groups of 10 animals each. Group I served as the normal healthy control, groups II rats were intoxicated with CCl4 i.p. (0.8 ml/kg body weight CCl4/olive oil, twice weekly for 9 weeks), group III rats received CCl4 i.p. and SFEE orally (150 mg/kg daily) and group IV rats received CCl4 i.p. and Silymarin orally (100 mg/kg, daily). The hepatoprotective potential of SFEE in rats was evaluated by measuring the protein levels of two inflammatory biomarkers; tumor necrosis factor-alpha (TNF-α) and nuclear factor kappa-B (NF-kB) in addition to other liver biomarkers. Histopathological changes in the liver were assessed using hematoxylin and eosin staining (HE).

resultsThe administration of SFEE showed hepatic protection at an oral dose of 150 mg/kg. SFEE significantly reduced the elevated serum levels of intracellular liver enzymes as well as liver biomarkers in comparison to CCl4- intoxicated group. Notably, SFEE significantly reduced the expression levels of TNF-α and NFkB proteins compared to their levels in CCl4 intoxicated group. These findings were confirmed with the histopathological observations, where SFEE was capable of reversing the toxic effects of CCl4 on liver cells compared to that observed in CCl4-intoxicated animals.

conclusionOur results show that SFEE has potential hepatoprotective effects at 150 mg/kg. These effects can be regarded to the antioxidant and anti-inflammatory properties of the extract.

Indexed as

AnimalsCarbon TetrachlorideChemical and Drug Induced Liver InjuryFemaleLipid PeroxidationLiverMalePlant ExtractsProtective AgentsRandom AllocationRatsSalixSilymarinCarbon TetrachloridePlant ExtractsProtective AgentsSilymarinCarbon tetrachlorideHepatoprotectiveLiver injuryNFkBSalix SubserrataSilymarinTNF-α

Identifiers

PMID27473536
PMCPMC4966707
OpenAlexW2495031229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.